Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Background: Basket trials are an innovative type of clinical trial primarily used in oncology. A distinctive feature of these studies is the grouping of patients based on specific molecular characteristics, such as genetic mutations or immunological subtypes, rather than traditional criteria like the type of cancer.
Material And Methods: This review was conducted in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. Medical databases were searched for studies published between 2014 and 2024. The inclusion criteria focused on basket trials as a clinical trial model in oncology.
Objectives: This work aims to outline the principles of conducting basket trials in oncology, analyze basket trials from the past decade, and highlight the emerging trends in this type of trial.
Results: The analysis of 76 articles meeting the inclusion criteria revealed that most of these studies are conducted as phase II clinical trials. The average duration of the basket trials in the analysis was 5.9 years (mean = 5.05), with an average recruitment target of 326 patients (mean = 123.5). Most of these studies were conducted in the USA, and the majority of basket trials focused on patients with solid tumors.
Conclusion: The systematic review confirms that basket trials have significant potential as a clinical trial model, as evidenced by the increasing number of basket trial projects being conducted.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.17219/acem/204832 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
A phase II randomized trial of individualized neoantigen peptide vaccine combined with unusual radiotherapy (iNATURE) in advanced solid tumors-GCOG0028.
Front Immunol
September 2025
Department of Clinical Oncology, University of Hong Kong-Shenzhen Hospital, Shenzhen, China.
Background: Neoantigen-based vaccines show promising therapeutic potential in solid tumors such as melanoma, GBM, NSCLC, and CRC. However, clinical responses remain suboptimal in stage IV patients, due to ineffective T-cell function and high tumor burdens. To overcome these limitations, our study investigates a combination strategy using neoantigen peptide vaccines and precision critical lesion radiotherapy (CLERT), which delivers immunomodulatory doses to key tumor regions synergistically enhance immune activation and inhibit progression in multifocal stage IV patients.
View Article and Find Full Text PDFBasket trial designs in oncology: A comprehensive systematic review.
Adv Clin Exp Med
September 2025
Department of Hypertension, Angiology and Internal Diseases, Poznan University of Medical Sciences, Poland.
Background: Basket trials are an innovative type of clinical trial primarily used in oncology. A distinctive feature of these studies is the grouping of patients based on specific molecular characteristics, such as genetic mutations or immunological subtypes, rather than traditional criteria like the type of cancer.
Material And Methods: This review was conducted in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines.
Efficacy of a Nutritional Intervention in Children with Moderate Acute Malnutrition: A Randomized Controlled Trial in Sri Lanka During the Economic Crisis in 2023.
Food Nutr Bull
September 2025
Sri Lanka College of Paediatricians, Colombo, Sri Lanka.
IntroductionUndernutrition continues to be a significant public health concern, particularly among children under 5 years.ObjectivesThis study evaluated the efficacy of an additional nutritional intervention in improving growth parameters, dietary diversity and haemoglobin levels in children aged 6 to 59 months with moderate acute malnutrition (MAM) during the 2023 economic crisis in Sri Lanka.MethodsThis was a randomized-controlled trial and children with MAM were randomly allocated to either the intervention group, receiving additional food transfers and nutrition education, or the control group, receiving standard care.
View Article and Find Full Text PDFCoronary Angioplasty with Drug-Coated Balloons: Pharmacological Foundations, Clinical Efficacy, and Future Directions.
Medicina (Kaunas)
August 2025
Emergency Clinical Hospital Dr. Bagdasar-Arseni, 041915 Bucharest, Romania.
Drug-coated balloons (DCBs) have transformed percutaneous coronary intervention (PCI) by delivering antiproliferative drugs directly to the arterial wall, offering a stent-less approach that mitigates the risks associated with permanent metallic implants. Initially developed for in-stent restenosis (ISR), DCBs have demonstrated robust efficacy in reducing neointimal hyperplasia and target lesion revascularization (TLR) rates across diverse coronary lesions, including small vessel disease (SVD), de novo lesions, and complex anatomies such as bifurcation lesions. Paclitaxel-coated balloons have long been the cornerstone of DCB therapy due to their established clinical outcomes, but sirolimus-coated balloons are emerging as a promising alternative with potentially superior safety profiles and sustained drug release.
View Article and Find Full Text PDFIncorporating data from multiple ongoing trials for Bayesian two-stage phase II single-arm studies.
Clin Trials
August 2025
Dana Farber Cancer Institute, Boston, MA, USA.
Background/aim: Basket designs have been utilized in recent oncology clinical trials due to an increased interest in precision medicine. One current successful basket trial is the American Society for Clinical Oncology Targeted Agent and Profiling Utilization Registry (TAPUR) study, a pragmatic phase II trial where patients are matched based on their tumor genomic profile to treatments that target specific genomic alterations. Despite its success, recruiting patients with rare genomic alterations remains challenging.
View Article and Find Full Text PDF